Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips.
作者信息
Villalobos Alexander, Pisanie Johannes L du, Gandhi Ripal T, Kokabi Nima
机构信息
Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
出版信息
Semin Intervent Radiol. 2024 Mar 14;41(1):63-78. doi: 10.1055/s-0044-1779715. eCollection 2024 Feb.
Abstract
摘要
相似文献
1
Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips.
Semin Intervent Radiol. 2024 Mar 14;41(1):63-78. doi: 10.1055/s-0044-1779715. eCollection 2024 Feb.
2
Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model.
EJNMMI Phys. 2022 Mar 21;9(1):21. doi: 10.1186/s40658-022-00447-1.
3
Post-administration dosimetry in yttrium-90 radioembolization through micro-CT imaging of radiopaque microspheres in a porcine renal model.
Phys Med Biol. 2021 Apr 27;66(9). doi: 10.1088/1361-6560/abf38a.
4
A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres.
Front Oncol. 2014 May 22;4:121. doi: 10.3389/fonc.2014.00121. eCollection 2014.
5
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
6
Utilizing 3D Slicer to incorporate tomographic images into GATE Monte Carlo simulation for personalized dosimetry in yttrium-90 radioembolization.
Med Phys. 2022 Dec;49(12):7742-7753. doi: 10.1002/mp.15980. Epub 2022 Sep 28.
7
3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.
Phys Med. 2020 Dec;80:317-326. doi: 10.1016/j.ejmp.2020.11.016. Epub 2020 Nov 25.
8
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres.
EJNMMI Phys. 2021 Oct 30;8(1):71. doi: 10.1186/s40658-021-00413-3.
9
Quantitative evaluation of Y-PET/CT and Y-SPECT/CT-based dosimetry following Yttrium-90 radioembolization.
Med Phys. 2024 Sep;51(9):6061-6074. doi: 10.1002/mp.17175. Epub 2024 May 23.
10
Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres.
Med Phys. 2019 May;46(5):2394-2402. doi: 10.1002/mp.13444. Epub 2019 Mar 12.
引用本文的文献
1
Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection.
J Korean Soc Radiol. 2025 Jul;86(4):447-456. doi: 10.3348/jksr.2025.0049. Epub 2025 Jul 25.
2
Radioembolization: Technical Tips and Follow-Up Imaging.
J Korean Soc Radiol. 2025 Jul;86(4):457-469. doi: 10.3348/jksr.2025.0032. Epub 2025 Jul 25.
3
Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective.
Korean J Radiol. 2025 Jul;26(7):688-703. doi: 10.3348/kjr.2025.0308. Epub 2025 Jun 4.
本文引用的文献
1
Transarterial radioembolization: a systematic review on gaining control over the parameters that influence microsphere distribution.
Drug Deliv. 2023 Dec;30(1):2226366. doi: 10.1080/10717544.2023.2226366.
2
Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres.
J Vasc Interv Radiol. 2023 Jul;34(7):1226-1234. doi: 10.1016/j.jvir.2023.02.030. Epub 2023 Mar 21.
3
Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series.
Cardiovasc Intervent Radiol. 2023 Apr;46(4):460-469. doi: 10.1007/s00270-023-03388-z. Epub 2023 Feb 28.
4
Cancer Immunology: Impact of Radioembolization of Hepatocellular Carcinoma on Immune Response Modulation.
AJR Am J Roentgenol. 2023 Jun;220(6):863-872. doi: 10.2214/AJR.22.28800. Epub 2023 Feb 8.
5
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1743-1752. doi: 10.1007/s00259-023-06111-9. Epub 2023 Jan 18.
6
Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
Cardiovasc Intervent Radiol. 2023 Jan;46(1):60-68. doi: 10.1007/s00270-022-03314-9. Epub 2022 Nov 30.
7
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):328-343. doi: 10.1007/s00259-022-05956-w. Epub 2022 Sep 17.
8
Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma.
Hepatol Commun. 2022 Nov;6(11):3223-3233. doi: 10.1002/hep4.2072. Epub 2022 Sep 5.
9
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.
Curr Oncol. 2022 Aug 4;29(8):5489-5507. doi: 10.3390/curroncol29080434.
10
Trans-arterial Radioembolization Dosimetry in 2022.
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1608-1621. doi: 10.1007/s00270-022-03215-x. Epub 2022 Aug 18.
Zotero 插件